Thermo Fisher Webinars
-
Achieving High Purity In Complex Antibody Formats
7/29/2025
Discover innovative purification strategies and workflow designs for next-generation antibody formats and learn to overcome challenges in achieving high purity and yield.
-
Developing A 2-Step Chromatographic Process For The Purification Of AAV Vectors
6/24/2025
POROS CaptureSelect AAVX and POROS 50 HQ were tested for capture and polishing, respectively, of AAV2, AAV9 and a novel engineered capsid to achieve vectors with high purity and significant empty: full ratio improvement.
-
Isolating CD4 / CD8 T Cells For Improved Drug Efficacy, Productivity
6/2/2025
Learn how the active detachment of dynabeads from target cells at any time allows users to add flexibility and scalability to their process.
-
CAR-T Innovation: Balancing Allogeneic And Autologous Cell Therapy
6/30/2025
Join experts as they discuss strategies for optimizing allogeneic and autologous therapies, aiming for balanced development and wider patient accessibility by 2030.
-
Advances In Flow-Through Technology To Enhance mAb Polishing
5/27/2025
Walk through three case studies that illustrate how novel chromatographic tools can improve the purification process for complex therapeutics by reducing aggregates and HCPs and effectively clearing retroviruses.
-
Rapid Micro Methods In QC Micro Testing: A NIBRT Perspective
5/29/2025
Learn about some of the advanced Rapid Micro Method systems that are being adopted by biopharma companies worldwide, and how they are changing the face of QC Microbiological testing.
-
Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective
2/18/2025
Discover efficient downstream processing strategies for antibody-based therapeutics. Explore key considerations and trade-offs in purity, yield, speed, and cost, from a CDMO perspective.
-
Advancing Vaccine Development With Novel Chromatography Solutions & Quality Testing
6/24/2025
Learn more on novel chromatography solutions that can help improve the downstream processes of different vaccine types such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).
-
Global Strategies For Resilience And Redundancy In Cell Culture Media Supply
7/17/2025
Ensure your cell culture media supply remains uninterrupted. Explore proactive strategies for global manufacturing equivalency and consistent media delivery.
-
Knowledge Culture: Downstream Innovation
6/2/2025
In this workshop, you’ll learn about various solutions, from cell isolation to cell expansion, that can support autologous and allogeneic cell therapy process needs, digital automation, and mycoplasma testing.